282 related articles for article (PubMed ID: 27408876)
21. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
[TBL] [Abstract][Full Text] [Related]
22. An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study.
Zhang XP; Gao YZ; Chen ZH; Chen MS; Li LQ; Wen TF; Xu L; Wang K; Chai ZT; Guo WX; Shi J; Xie D; Wu MC; Yee Lau W; Cheng SQ
Hepatology; 2019 May; 69(5):2076-2090. PubMed ID: 30586158
[TBL] [Abstract][Full Text] [Related]
23. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
Wang Z; Liu G; Lu MD; Xie X; Kuang M; Wang W; Xu Z; Lin M; Chen L
Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
[TBL] [Abstract][Full Text] [Related]
24. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
25. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
[TBL] [Abstract][Full Text] [Related]
26. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
[TBL] [Abstract][Full Text] [Related]
27. Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion.
Aldrighetti L; Pulitanò C; Catena M; Arru M; Guzzetti E; Halliday J; Ferla G
Ann Surg Oncol; 2009 May; 16(5):1254. PubMed ID: 19277788
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Shi J; Lai EC; Li N; Guo WX; Xue J; Lau WY; Wu MC; Cheng SQ
Ann Surg Oncol; 2010 Aug; 17(8):2073-80. PubMed ID: 20131013
[TBL] [Abstract][Full Text] [Related]
29. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J
Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279
[TBL] [Abstract][Full Text] [Related]
30. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics.
Jia L; Kiryu S; Watadani T; Akai H; Yamashita H; Akahane M; Ohtomo K
Acta Med Okayama; 2012; 66(2):131-41. PubMed ID: 22525471
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
32. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
[TBL] [Abstract][Full Text] [Related]
33. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
[TBL] [Abstract][Full Text] [Related]
34. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
[TBL] [Abstract][Full Text] [Related]
35. [Malignant tumor with false negative 18F-FDG PET image].
Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study.
Tarantino L; Busto G; Nasto A; Fristachi R; Cacace L; Talamo M; Accardo C; Bortone S; Gallo P; Tarantino P; Nasto RA; Di Minno MN; Ambrosino P
World J Gastroenterol; 2017 Feb; 23(5):906-918. PubMed ID: 28223736
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.
Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q
Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783
[TBL] [Abstract][Full Text] [Related]
38. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
39. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
[TBL] [Abstract][Full Text] [Related]
40. Experimental study on enhancement of the metastatic potential of portal vein tumor thrombus-originated hepatocellular carcinoma cells using portal vein serum.
Tang Y; Yu H; Zhang L; Wang K; Guo W; Shi J; Liu S; Wu M; Wang H; Cheng S
Chin J Cancer Res; 2014 Oct; 26(5):588-95. PubMed ID: 25400425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
